NEUROMUSCULAR MANIFESTATIONS
Clinical trials for NEUROMUSCULAR MANIFESTATIONS explained in plain language.
Never miss a new study
Get alerted when new NEUROMUSCULAR MANIFESTATIONS trials appear
Sign up with your email to follow new studies for NEUROMUSCULAR MANIFESTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy takes aim at muscle weakness disease
Disease control Recruiting nowThis early-stage study tests a new treatment called anito-cel for people with generalized myasthenia gravis, a condition causing muscle weakness. Anito-cel is a type of CAR-T cell therapy that targets specific immune cells to reduce disease activity. The study will enroll about 3…
Matched conditions: NEUROMUSCULAR MANIFESTATIONS
Phase: PHASE1 • Sponsor: Arcellx, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for SMA babies: drug trial aims to boost motor milestones
Disease control Recruiting nowThis study tests a drug called apitegromab in babies under 2 years old who have spinal muscular atrophy (SMA), a genetic condition that weakens muscles. The goal is to see if the drug can improve motor skills like sitting and crawling. All participants must already be on standard…
Matched conditions: NEUROMUSCULAR MANIFESTATIONS
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC